Dr. Samuel Gandy
- 336 Publications
Dr. Samuel Gandy and his team are credited with discovering the first drugs that could decrease formation of amyloid, a substance that clogs the brain in Alzheimer’s disease patients, in 1989. His most recent work in 2018 uncovered the discovery that two strains of HIV in the brains of people with Alzheimer’s are twice as high as that found in people without Alzheimer’s.
Dubbed one of GQ magazine’s “Rock Stars of Science” in 2010, he is currently the Mount Sinai Professor of Alzheimer's Disease Research, Professor of Neurology and Psychiatry, Associate Director of the Mount Sinai Alzheimer's Disease Research Center in New York City, and Chairman Emeritus of the National Medical and Scientific Advisory Council of the Alzheimer's Association.